A defence mechanism that can trap and kill TB bacteria

May 10, 2017, The Francis Crick Institute
Macrophages (shown with blue nuclei) trap tuberculosis bacteria inside both tight and spacious phagosomes (red rings). Credit: Laura Schnettger, Francis Crick Institute

A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.

The findings, published in Cell Host & Microbe, could enable scientists to develop treatments for TB - one of the world's biggest health challenges - without the use of antibiotics, meaning that even antibiotic-resistant strains could be eliminated. The research was done in collaboration with scientists at the University of Oslo, the Max Planck Institute for Infection Biology in Germany and the Radboud Institute for Molecular Life Sciences in the Netherlands.

"We are trying to better understand how our cells kill the bacteria with the idea of boosting people's natural defences in conjunction with conventional therapies to overcome TB," says Maximiliano Gutierrez, Group Leader at the Francis Crick Institute, who led the study.

Immune cells called macrophages recognise and engulf Mycobacterium tuberculosis - the bacterium responsible for TB - securing it within tight-fitting internal compartments known as phagosomes.

But before enzymes and toxic products can enter the to kill the bacterium, M. tuberculosis often escapes by puncturing holes in the phagosome membrane and leaking into the cell. In doing so, M. tuberculosis kills the cell and then feeds on its nutrients.

By imaging the infection of cells with TB bacteria in real time, the team uncovered an innate mechanism that prevents M. tuberculosis from damaging phagosomes: the phagosomes are enlarged so that the bacterium can't easily reach and puncture holes in the membrane. This gives the cell enough time for bacteria-killing weapons to enter before the bacterium has a chance to escape.

"We have known for a while that tight and spacious phagosomes exist, but it is only now becoming clear why there are two types," says Laura Schnettger, the first author of the paper and former PhD student in Maximiliano's lab at the Crick.

By tagging different components in the macrophage with fluorescent markers, the team were able to see the enlarging of M. tuberculosis-containing phagosomes in real time under the microscope. They observed that M. tuberculosis failed to escape from these enlarged membrane sacs and that antibacterial components were delivered more efficiently.

The team discovered that when macrophages are set to work engulfing M. tuberculosis, a protein known as Rab20 delivers additional membrane material to M. tuberculosis-containing phagosomes to enlarge them.

"If you think of a cell as a city with lots of different types of transport then Rab proteins are the master regulators of public transport. They tell components in a cell where to go," explains Maximiliano. "Rab20 directs more membrane to the phagosome, enlarging it and preventing the bacteria from getting out."

The team also analysed the typical coughed-up material from human patients with active TB. They found that these patients had more Rab20 in their body than people without TB, supporting the idea that Rab20 is important in fighting the TB infection.

"A very high proportion of people that are likely exposed to M. tuberculosis, are able to clear the infection without developing full-blown TB," says Maximiliano. "It is possible that the body's natural mechanism to enlarge phagosomes plays a part in this."

"The capture and escape of M. tuberculosis in cells is a highly dynamic process, so the only way you can understand what is going on is to image in at very high resolution. We are one of the few labs in the world that can perform long-term live cell imaging at sub-cellular resolution with the safety infrastructure required to work with a life-threatening bacterium."

Explore further: Tuberculosis and HIV co-infection

More information: Laura Schnettger et al, A Rab20-Dependent Membrane Trafficking Pathway ControlsM. tuberculosisReplication by Regulating Phagosome Spaciousness and Integrity, Cell Host & Microbe (2017). DOI: 10.1016/j.chom.2017.04.004

Related Stories

Tuberculosis and HIV co-infection

October 18, 2016
The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system. This is the conclusion of a study carried out by researchers at Linköping University in Sweden. ...

New drug lead identified in fight against tuberculosis

March 1, 2017
Antibacterial compounds found in soil could spell the beginnings of a new treatment for tuberculosis, new research led by the University of Sydney has found.

Curcumin may help overcome drug-resistant tuberculosis

March 24, 2016
New research indicates that curcumin—a substance in turmeric that is best known as one of the main components of curry powder—may help fight drug-resistant tuberculosis. In Asia, turmeric is used to treat many health ...

A 'release and kill' strategy may aid treatment of tuberculosis

February 8, 2017
Mycobacterium tuberculosis has been called "the perfect pathogen." These bacteria hijack human macrophages, persist inside the cells to evade immune destruction, and then prevent the macrophage from undergoing programmed ...

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.